Incyte Earnings, Revenue Beat in Q2
Investing.com - Incyte (NASDAQ:INCY) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $0.75 on revenue of $529.9M. Analysts polled by Investing.com anticipated EPS of $0.28 on revenue of $496.42M. That compared to EPS of $0.24 on revenue of $421.52M in the same period a year earlier. The company had reported EPS of $0.47 on revenue of $497.86M in the previous quarter.
Incyte follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analysts' expectations on July 18, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Celgene Earnings Miss, Revenue Beats In Q2
Eli Lilly tops revenue estimates on diabetes drug boost
Karmic reckoning? Investors in activist hedge funds agitate for change
